Pharmaceutical Technology

AUGUST 5, 2024

Kerendia’s Phase III study met its primary endpoint by reducing the risk of cardiovascular death and heart failure.

Cardiology 130

Cardiology 130

pharmaphorum

APRIL 23, 2021

Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. . The post UK regulator backs Amarin’s cardiology drug Vazkepa appeared first on. Icosapent ethyl also demonstrated a 26% relative risk reduction and a 3.6%

Cardiology 98

Cardiology Regulation Drugs Licensing 98

Scienmag

APRIL 7, 2022

Through a shared commitment to transforming cardiovascular care, the American College of Cardiology is partnering with the Korean Society of Cardiology (KSC) to host ACC Asia 2022 Together with KSC Spring Conference, taking place April 15-16, 2022, in Gyeongju, South Korea and virtually. Led by conference co-chairs Fred M.

Cardiology 56

Cardiology 56

CTTI (Clinical Trials Transformation Initiative)

DECEMBER 21, 2022

It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies. The post It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies appeared first on CTTI.

Cardiology 40

Cardiology Clinical Trials Clinical Trials Trials 40

Pharmaceutical Technology

SEPTEMBER 5, 2023

A new set of European Society of Cardiology (ESC) guidelines was shared at the 2023 ESC conference in Amsterdam, Netherlands.

Cardiology 246

Cardiology 246

Scienmag

MAY 11, 2021

While patients are embracing telemedicine, significant numbers of cardiology trainees are uncomfortable with telemedicine according to survey results reported in the Canadian Journal of Cardiology Philadelphia, May 12, 2021 – The COVID-19 pandemic has resulted in an abrupt change in healthcare delivery, including a shift from in-person visits (..)

Cardiology 43

Cardiology Medicine 43

BioTech 365

NOVEMBER 8, 2021

Philips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of Cardiologs Philips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of Cardiologs November 8, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: … Continue reading →

Cardiology 40

Cardiology 40

JAMA Internal Medicine

JULY 14, 2024

This cohort study evaluates marketing payments from pharmaceutical and medical device manufacturers to physician trainees before and after fellowship graduation.

Cardiology 43

Cardiology Manufacturing Marketing 43

Scienmag

DECEMBER 15, 2020

National study will accelerate initiation of lipid lowering therapies in ACS patients to prevent future cardiovascular events The American College of Cardiology, in collaboration with Amgen and Veradigm, today announced a new national study to transform care for acute coronary syndrome (ACS) patients at risk for future cardiovascular events.

Cardiology 51

Cardiology Medicine 51

BioTech 365

APRIL 17, 2021

Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment … Continue reading →

Cardiology 52

Cardiology 52

Rethinking Clinical Trials

JULY 24, 2024

Fonarow is the Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA, director of the Ahmanson-UCLA Cardiomyopathy Center, and codirector of the UCLA Preventative Cardiology Program. Join the online meeting.

Cardiology 162

Cardiology Clinical Trials Clinical Trials Medicine 162

BioTech 365

MAY 17, 2021

Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences Minimally-invasive, implant-free technology for heart failure patients studied at 1 … Continue reading →

Cardiology 52

Cardiology 52

Fierce Pharma

SEPTEMBER 1, 2024

At the European Society of Cardiology (ESC) event, Bayer unveiled data from the 3 FINEARTS-HF trial that showed Kerendia reduced the risk of cardiovascular death, as well as well as first and recurrent HF events by 16% compared to placebo in patients with mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF).

Cardiology 111

Cardiology Trials 111

Scienmag

APRIL 5, 2021

What The Study Did: Electronic health record data were used to examine whether the transition to remote cardiology clinic visits during COVID-19 is associated with disparities in patient use of care, diagnostic test ordering and medication prescribing. Authors: Neal Yuan, M.D.,

Cardiology 40

Cardiology Medicine 40

pharmaphorum

SEPTEMBER 1, 2024

Alnylam Pharma has been riding high since revealing top-line results from its HELIOS-B trial of vutrisiran in transthyretin-mediated amyloidosis (ATTR) – but a look at the full data seems to have disappointed investors.Shares in the company retreated after the presentation of the results at the European Society of Cardiology (ESC) conference, which (..)

Cardiology 113

Cardiology Trials 113

BioTech 365

JUNE 18, 2021

Largest Real-World Registry Supporting Neovasc Reducer™ Safety and Efficacy Outcomes Published in International Journal of Cardiology Largest Real-World Registry Supporting Neovasc Reducer™ Safety and Efficacy Outcomes Published in International Journal of Cardiology VANCOUVER and MINNEAPOLIS, June 18, 2021 (GLOBE NEWSWIRE) … Continue (..)

Cardiology 40

Cardiology 40

Pharmaceutical Technology

AUGUST 25, 2023

Novo Nordisk is eyeing the cardiology treatment space for its highly sought-after drug that is dominating the weight loss and diabetes drug landscape.

Cardiology 130

Cardiology Drugs 130

BioTech 365

FEBRUARY 26, 2021

Global Chemiluminescence Immunoassay Market Analysis, 2020-2027 – Focus on Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease – ResearchAndMarkets.com Global Chemiluminescence Immunoassay Market Analysis, 2020-2027 – Focus on Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, (..)

Cardiology 40

Cardiology Marketing Drugs 40

XTalks

AUGUST 14, 2024

He serves as director of Atlantic Health System Sports Cardiology and director of the Chanin T. Dr. Martinez also serves as a cardiology consultant for elite and professional athletes, including acting as the League cardiologist for Major League Soccer, team cardiologist for the New York Jets and cardiac consultant for the NFL and NHL.

Life Science 72

Life Science Cardiology FDA Approval Medicine 72

Bio Pharma Dive

AUGUST 6, 2020

A talk with the American College of Cardiology about how they are working with Health IT to deliver their guidance to the point-of-care.

Cardiology 278

Cardiology 278

BioTech 365

SEPTEMBER 25, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New atlas of the human heart could guide personalized medicine in cardiology.New atlas of the human heart could guide personalized medicine in cardiology arlene.weintraub Fri, 09/25/2020 – … Continue reading → (..)

Cardiology 40

Cardiology Medicine Research 40

Medical Xpress

DECEMBER 1, 2022

Emergency visits for stroke are elevated after a heatwave, according to research presented today at ESC Asia, a scientific congress organized by the European Society of Cardiology (ESC), the Asian Pacific Society of Cardiology (APSC), and the Asean Federation of Cardiology (AFC).

Cardiology 98

Cardiology Research 98

JAMA Internal Medicine

JUNE 9, 2024

This cross-sectional study compares 10-year atherosclerotic cardiovascular disease risk and recommendations for primary prevention statin therapy between the 2023 American Heart Association (AHA) Predicting Risk of Cardiovascular Disease (CVD) Events (PREVENT) equations and the 2013 AHA/American College of Cardiology pooled cohort equations.

Cardiology 101

Cardiology 101

Rethinking Clinical Trials

JUNE 12, 2024

James and Oldgren are professors of cardiology in the Department of Medical Sciences and the Uppsala Clinical Research Center at Uppsala University. Join the online meeting. The post June 12, 2024: Registry-Based DAPA-MI Trial to Be Featured in This Week’s PCT Grand Rounds appeared first on Rethinking Clinical Trials.

Trials 147

Trials Cardiology Clinical Trials Clinical Trials 147

Rethinking Clinical Trials

JANUARY 17, 2024

Douglas is the Ursula Geller Professor of Research in Cardiovascular Diseases at Duke University and a past president of both the American College of Cardiology and the American Society of Echocardiography. The Grand Rounds session will be held on Friday, January 19, 2024, at 1:00 pm eastern. Join the online meeting.

Trials 147

Trials Cardiology Clinical Trials Clinical Trials 147

Medical Xpress

MARCH 7, 2023

Making a connection between the flu and the risk of subsequent heart problems significantly increased flu vaccination rates among older Danish adults, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

Cardiology 90

Cardiology Vaccination Vaccine 90

Fierce Pharma

AUGUST 30, 2024

a “grand slam” with data that position its RNA silencer Amvuttra (vutrisiran) to potentially be | At the European Society of Cardiology conference in London, Alnylam presented positive data from the phase 3 HELIOS-B trial which assessed RNA silencer Amvuttra (vutrisiran) as a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM).

Cardiology 64

Cardiology RNA Trials 64

pharmaphorum

APRIL 8, 2024

Drugs from Ionis and Arrowhead Pharma that block apolipoprotein C-III (apoC-III) have shown their value in treating diseases associated with elevated triglyceride levels in two studies presented at the American College of Cardiology annual congress.

Cardiology 111

Cardiology Drugs Marketing 111

Medical Xpress

FEBRUARY 24, 2023

People who suffer from insomnia were 69% more likely to have a heart attack compared to those who didn't have the sleep disorder during an average nine years of follow-up, according to new research being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

Cardiology 98

Cardiology Research 98

BioTech 365

DECEMBER 1, 2020

LUCA Science Announces Joint Research With Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine on the Development of Mitochondrial Therapy for Myocardial Infarction (Cardiac Ischemic-reperfusion Injury) LUCA Science Announces Joint Research With Division of Cardiology, … Continue reading →

Cardiology 52

Cardiology Medicine Development Research 52

Medical Xpress

MAY 16, 2023

All women should know their blood pressure to prevent heart disease and stroke, urged cardiologists from the European Society of Cardiology (ESC) on World Hypertension Day.

Cardiology 97

Cardiology 97

BioTech 365

OCTOBER 2, 2020

–(BUSINESS WIRE)–The Journal of the American College of Cardiology published results of the Phase III GadaCAD 1 and GadaCAD 2 clinical trials for … Continue reading → Coronary artery disease (CAD) is a critical public health issue, affecting an estimated 16.5 million Americans1 WHIPPANY, N.J.–(BUSINESS

Cardiology 52

Cardiology Clinical Trials Clinical Trials Trials 52

Medical Xpress

MARCH 7, 2023

times as likely to prescribe mineralocorticoid receptor antagonists (MRAs), a guideline-recommended class of heart failure medication, compared with doctors who did not receive such alerts, according to research being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

Cardiology 81

Cardiology Doctors Doctor Research 81

BioTech 365

APRIL 17, 2021

VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021 VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE … Continue reading →

Cardiology 40

Cardiology 40

BioTech 365

MAY 16, 2021

Cytokinetics Announces Presentations Related to Health Economics and Outcomes Research in Heart Failure and Hypertrophic Cardiomyopathy at American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21)

Cardiology 40

Cardiology Research 40

Medical Xpress

APRIL 18, 2023

A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation ablation, according to late breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).

Cardiology 105

Cardiology 105

BioTech 365

MAY 17, 2021

Attralus Announces Presentation of Clinical Data on AT-01, a Novel, Potential First-in-Class Diagnostic for Systemic Amyloidosis at the 2021 American College of Cardiology Annual Meeting Attralus Announces Presentation of Clinical Data on AT-01, a Novel, Potential First-in-Class Diagnostic for Systemic … Continue reading →

Cardiology 52

Cardiology 52